Canntab Therapeutics Limited Stock Canadian Securities Exchange
Equities
PILL
CA1377991023
Pharmaceuticals
Sales 2021 | - | Sales 2022 | 0.29 0.4 | Capitalization | 9.99M 13.69M |
---|---|---|---|---|---|
Net income 2021 | -4M -5.48M | Net income 2022 | -3M -4.11M | EV / Sales 2021 | - |
Net Debt 2021 | 75.05K 103K | Net Debt 2022 | 1.15M 1.58M | EV / Sales 2022 | 37,969,265 x |
P/E ratio 2021 |
-7.9
x | P/E ratio 2022 |
-2.63
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 86.26% |
1st Jan change | Capi. | |
---|---|---|
+29.99% | 5.69B | |
-31.99% | 3.53B | |
-0.59% | 3.06B | |
-24.15% | 2.62B | |
-9.23% | 2.29B | |
+42.55% | 1.86B | |
+44.37% | 1.43B | |
-11.29% | 1.41B | |
+42.86% | 1.4B |